The Epilepsy Foundation, headquartered in Bowie, MD, and Iaso Ventures, based in Boston, MA, have announced a groundbreaking partnership to establish the Iaso NeuroImpact Fund.
This venture philanthropy fund is dedicated to providing primary funding to accelerate the development of new therapeutics, diagnostics, and technologies aimed at revolutionizing the care landscape for epilepsy and seizure disorders.
Advancing Treatment Paradigms:
Companies supported by the Iaso NeuroImpact Fund are poised to redefine epilepsy treatment paradigms with their innovative approaches.
These initiatives encompass a diverse range of applications, including therapeutic development, seizure forecasting, rescue therapies, pediatric seizure prevention, and treatments for rare diseases.
The fund seeks to catalyze transformative advancements in epilepsy care through strategic investment and support.
Epilepsy Foundation’s Mission:
The Epilepsy Foundation plays a crucial role in connecting individuals affected by epilepsy to treatment, support, and resources.
Additionally, the foundation leads advocacy efforts, funds innovative research, supports the training of specialists, and educates the public about epilepsy and seizure first aid.
Their partnership with Iaso Ventures reflects their commitment to driving progress in epilepsy care through collaborative initiatives.
About Iaso Ventures:
Led by Managing Partner Wasim Malik, Iaso Ventures specializes in venture capital investments within the healthcare and life sciences sector.
The firm focuses on supporting companies that develop innovative technologies and solutions with the potential to deliver transformative impact for patients.
Through strategic partnerships with research hospitals, disease foundations, pharmaceutical and medical technology companies, Iaso Ventures aims to create a unique innovation ecosystem that fosters groundbreaking advancements in healthcare.
Driving Innovation in Healthcare:
Empowered by a robust partner network, portfolio companies supported by Iaso Ventures have pioneered applications in various domains, including AI-enabled drug discovery, drug design and delivery platforms, first-in-class therapeutics, and digital technologies for comprehensive support across the entire life sciences value chain.
The firm’s collaborative approach to investment underscores its commitment to driving innovation and improving patient outcomes in healthcare.
VCWire Announcement:
The announcement of the Epilepsy Foundation and Iaso Ventures’ partnership to establish the Iaso NeuroImpact Fund was featured on VCWire on March 20, 2024, marking a significant milestone in the advancement of epilepsy care and treatment innovation.
Share on Facebook «||»
Share on Twitter «||»
Share on Reddit «||»
Share on LinkedIn
RagaAI Secures Strategic Funding Round Led by pi Ventures, Backed by Anorak Ventures, TenOneTen Ventures etc: The latest funding round, spearheaded by pi Ventures, has seen active participation from notable investors, including Anorak Ventures, TenOneTen Ventures, Arka Ventures, Mana Ventures, and...
DNX Ventures Successfully Closes Japan Fund IV, Raising $122 Million, Alongside Japan Annex Fund III, Garnering $55 Million: DNX Ventures, a prominent venture capital firm, has achieved a significant milestone by successfully closing two funding rounds: Japan Fund IV and Japan Annex Fund...
5 Things You Should Know About Epilepsy, According to CDC: Epilepsy is a brain disorder that causes repeated seizures. There are many different types of epilepsy and many different kinds of seizures. Epilepsy can get...
Lack of oxygen at birth can cause epilepsy -neurologist: A Professor of Neurology, in University of Nigeria Nsukka, Dr. Ikenna Onwuekwe, has urged physicians and new mothers to pay good attention to babies during...
Access Bank and Nerdzfactory Foundation Collaborate – WDEP 3.0 Equips Female Entrepreneurs for Digital Transformation: The Women Digital Entrepreneurship Program (WDEP) is a comprehensive business growth initiative aimed at empowering women with the digital skills, knowledge, and resources necessary to...
OurCrowd AI Fund to Collaborate with NVIDIA Inception Program: OurCrowd AI Fund has recently unveiled its strategic collaboration with NVIDIA to offer a streamlined entry into the prestigious NVIDIA Inception program for select artificial...
Merck Foundation launches the Second Episode of “Our Africa by Merck Foundation” TV Program that raises awareness on Ending Child Marriage & Supporting Girl Education in Africa: Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany has launched the Second Episode of their first-ever TV program – ‘Our Africa by Merck...
Cross-Border Impact Ventures Successfully Closes Women’s and Children’s Health Technology Fund, Surpassing $90 Million: Cross-Border Impact Ventures Achieves Remarkable Closure of Women’s and Children’s Health Technology Fund Cross-Border Impact Ventures has achieved a significant milestone by successfully concluding the...
Sawari Ventures Unveils Ambitious $150 Million Fund to Boost Egyptian Startups Across Key Sectors: In a groundbreaking move, Sawari Ventures, a leading investment firm, announces the launch of a formidable $150 million fund dedicated to supporting and fostering growth...
ORI Capital Secures $260M for Its Second Life Sciences Fund, Embracing Innovation in Biotech Ventures: In a resounding move within the realm of life sciences investment, ORI Capital has successfully raised $260 million for its second life sciences fund. The...
